Cimoli G - Search Results

1

Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells.

Cimoli G, Russo P, Billi G, Mariani GL, Rovini E, Venturini M. Cimoli G, et al. Jpn J Cancer Res. 1991 Nov;82(11):1196-8. doi: 10.1111/j.1349-7006.1991.tb01779.x. Jpn J Cancer Res. 1991. PMID: 1752777 Free PMC article.

2

Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.

Orengo G, Noviello E, Cimoli G, Pagnan G, Parodi S, Venturini M, Conte P, Schenone F, Conzi G, Russo P. Orengo G, et al. Among authors: cimoli g. Jpn J Cancer Res. 1992 Nov;83(11):1132-6. doi: 10.1111/j.1349-7006.1992.tb02735.x. Jpn J Cancer Res. 1992. PMID: 1336489 Free PMC article.

3

Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.

Cimoli G, Valenti M, Venturini M, Conte P, Russo P. Cimoli G, et al. Anticancer Res. 1992 Sep-Oct;12(5):1411-4. Anticancer Res. 1992. PMID: 1444198

4

Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity.

Vigani A, Chiara S, Miglietta L, Repetto L, Conte PF, Cimoli G, Morelli L, Billi G, Parodi S, Russo P. Vigani A, et al. Among authors: cimoli g. Gynecol Oncol. 1991 Apr;41(1):52-5. doi: 10.1016/0090-8258(91)90254-3. Gynecol Oncol. 1991. PMID: 2026360

5

Effect of recombinant human TNF on human ovarian cancer cell lines.

Vigani A, Miglietta L, Chiara S, Repetto L, Pichi E, Cimoli G, Morelli L, Poggi L, Billi G, Parodi S, et al. Vigani A, et al. Among authors: cimoli g. Boll Soc Ital Biol Sper. 1990 Jun;66(6):537-42. Boll Soc Ital Biol Sper. 1990. PMID: 2257120

6

"Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3).

Cimoli G, Valenti M, Noviello E, Parodi S, Mazzoni A, Rovini E, De Sessa F, Russo P. Cimoli G, et al. J Cancer Res Clin Oncol. 1995;121(3):155-63. doi: 10.1007/BF01198097. J Cancer Res Clin Oncol. 1995. PMID: 7713987

7

Circumvention of atypical multidrug resistance with tumor necrosis factor.

Cimoli G, Valenti M, Parodi S, De Sessa F, Russo P. Cimoli G, et al. Jpn J Cancer Res. 1994 Feb;85(2):135-8. doi: 10.1111/j.1349-7006.1994.tb02073.x. Jpn J Cancer Res. 1994. PMID: 8144394 Free PMC article.

8

Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications.

Valenti M, Cimoli G, Parodi S, Mariani GL, Venturini M, Conte P, Russo P. Valenti M, et al. Among authors: cimoli g. Eur J Cancer. 1993;29A(8):1157-61. doi: 10.1016/s0959-8049(05)80307-7. Eur J Cancer. 1993. PMID: 8518027

9

Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks.

Noviello E, Aluigi MG, Cimoli G, Rovini E, Mazzoni A, Parodi S, De Sessa F, Russo P. Noviello E, et al. Among authors: cimoli g. Mutat Res. 1994 Nov 1;311(1):21-9. doi: 10.1016/0027-5107(94)90069-8. Mutat Res. 1994. PMID: 7526171

10

Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.

Cimoli G, Valenti M, Parodi S, Mazzoni A, De Sessa F, Conte P, Russo P. Cimoli G, et al. Oncol Res. 1993;5(8):311-23. Oncol Res. 1993. PMID: 8012063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters